Latest Regenerative iPSC News

Subscribe

Japan Government Panel Approves Research on Human Embryos Created from Stem Cells

Japanese officials move to update guidelines as researchers explore stem cell-derived human embryos for infertility and genetic studies.

Cedars-Sinai Sending Stem Cells to Space to Study Heart and Brain Organoids

Cedars-Sinai researchers will examine how microgravity affects the growth and development of heart and brain organoids in orbit.

Kyoto University Team Creates Jawbone Tissue from Human Stem Cells (iPSCs)

Researchers generated 3D jawbone tissue from induced pluripotent stem cells

GC Therapeutics’ Reports Cell Programming Breakthrough, Enhancing Cell Therapy Manufacturing

GC Therapeutics unveils data showing rapid, precise generation of human microglia-like cells, advancing scalable cell therapy production.

Pluristyx and BioLamina Join Forces to Enhance Stem Cell Therapy Development

The collaboration aims to streamline iPSC-based therapy development by integrating advanced cell engineering with specialized culture matrices.

Sumitomo Pharma Submits Application for Japanese Approval of Stem Cell Therapy to Enhance Motor Function in Parkinson’s Disease

Sumitomo Pharma and RACTHERA seek approval for a novel iPS cell-based therapy targeting motor symptoms in advanced Parkinson’s.

NASA’s New Mission will Study Stem Cell Expansion in Space

The Crew-11 mission launched on Friday, where they will support studies in stem cell growth, organ tissue, bacteriophage therapy, and advanced computing.

Trailhead Biosystems Launches New iPSC-Derived Neurons for Parkinson’s Research

The iPSC-derived A9 dopaminergic neurons will hopefully offer researchers a human-based model for Parkinson’s disease studies.

Stem Cell Pioneers: iPSC Discovery, Potential, and Manufacturing, Interview with Dr. Koji Tanabe

Dr. Koji Tanabe discusses IPS cell advancements, mass manufacturing, and their future in medicine.

Vita Therapeutics and I Peace Join Forces to Deliver Gene-Edited Stem Cells for Muscular Dystrophy

The companies will collaborate to leverage gene editing and GMP iPSC manufacturing to hopefully deliver new therapies.
Load More
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe